Immunotherapy in Epidermal Growth Factor Receptor-mutant Non-small Cell Lung Cancer
Targeted therapy and immunotherapy are important treatments for non-small cell lung cancer (NSCLC). At present, the clinical and basic research of epidermal growth factor receptor (EGFR) mutation NSCLC is still in the exploratory stage, needing to optimize the efficacy, combination, sequence and dos...
Wedi'i Gadw mewn:
| Prif Awduron: | , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Chinês |
| Cyhoeddwyd: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2019-08-01
|
| Cyfres: | Chinese Journal of Lung Cancer |
| Pynciau: | |
| Mynediad Ar-lein: | http://dx.doi.org/10.3779/j.issn.1009-3419.2019.08.11 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|